Hormone replacement therapy and breast cancer: estimate of risk

Nathan J Coombs; Richard Taylor; Nicholas Wilcken; John Boyages

doi:10.1136/bmj.331.7512.347

Hormone replacement therapy and breast cancer: estimate of risk

BMJ. 2005 Aug 6;331(7512):347-9. doi: 10.1136/bmj.331.7512.347.

Authors

Nathan J Coombs¹, Richard Taylor, Nicholas Wilcken, John Boyages

Affiliation

¹ New South Wales Breast Cancer Institute, University of Sydney, Westmead Hospital, Westmead, NSW 2145, Australia.

Abstract

Patients often ask how population risk data apply to them. This analysis will help doctors to answer that question for women considering hormone replacement therapy

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Breast Neoplasms / chemically induced*
Female
Hormone Replacement Therapy / adverse effects*
Humans
Middle Aged
Risk Assessment*
Risk Factors
Time Factors